Bausch Health Companies (BHC) EPS (Diluted) Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bausch Health Companies (BHC) EPS (Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.81 Bn | 39.16 Bn | 2.15 Bn | -304.28% |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -2,504.14% |
| 3 | Dr Reddys Laboratories | 9.90 Bn | 9.73 Bn | 396.53 Mn | -71.69% |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | 92.07% |
| 5 | Bausch Health Companies | 2.32 Bn | 479.50 Mn | 2.10 Bn | 100.44% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.12 Bn | 165.89 Mn | 181.09% |
| 8 | Amphastar Pharmaceuticals | 997.70 Mn | 707.58 Mn | 93.47 Mn | 6.43% |
| 9 | Fennec Pharmaceuticals | 395.89 Mn | 354.64 Mn | 17.15 Mn | 147.53% |
| 10 | RedHill Biopharma | 179.21 Mn | 179.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.44% |
| Mar 31, 2026 | -1,549.67% |
| Dec 31, 2025 | -203.14% |
| Sep 30, 2025 | 293.02% |
| Jun 30, 2025 | 12,800.51% |
| Mar 31, 2025 | -10.84% |
| Dec 31, 2024 | 306.75% |
| Sep 30, 2024 | 76.11% |
| Jun 30, 2024 | -103.67% |
| Mar 31, 2024 | 63.51% |
| Dec 31, 2023 | 88.63% |
| Sep 30, 2023 | -194.27% |
| Jun 30, 2023 | 119.17% |
| Mar 31, 2023 | -214.49% |
| Dec 31, 2022 | -664.57% |
| Sep 30, 2022 | 111.34% |
| Jun 30, 2022 | 76.76% |
| Mar 31, 2022 | 89.25% |
| Dec 31, 2021 | 146.55% |
| Sep 30, 2021 | 164.43% |